Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenesis Chooses BlueArc for Storage Architecture

NEW YORK, March 11 - The chemical genomics company NeoGenesis has chosen BlueArc to provide a storage architecture for its drug discovery data, the companies said today.

 

NeoGenesis, of Cambridge, Mass., has an automated ligand identification system for screening protein targets associated with disease, and a NeoMorph compound library of 10 million molecules. The company said it generates between five and 20 gigabytes of data per day, per screening line, and can generate more than 2 terabytes per month, with the requirement that the data remain online for about three months. 

 

Blue Arc's Si7500 SiliconServer architecture has been installed at NeoGenesis to store data from its work.

 

"BlueArc's hardware-based solution eliminates the dependency on software, which we saw as a crippling factor in other NAS solutions," Tomas Revesz, director of Information Systems for NeoGenesis, said in a statement.

 

This deal comes as BlueArc, of San Jose, Calif., makes a public foray into the life sciences with the establishment of a life sciences IT practice.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.